FDA: Docs should check on patients who got other drugs made by pharmacy in meningitis outbreak
NEW YORK, N.Y. – Health officials have broadened their warning to doctors about other medicines made by a specialty pharmacy linked to a meningitis outbreak.
The Food and Drug Administration took the step Monday because of reports of new illnesses that may be tied to other products made by the same company, the New England Compounding Center of Framingham, Mass.
Now health officials want doctors to contact patients who got any injection made by the company and warn them of the risk of infection.
A steroid made by the pharmacy has been tied to a national outbreak of a rare fungal form of meningitis that has killed 15.
The new reports include meningitis in a patient who got another company steroid and fungal infections in two heart transplant patients.
News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.
Join the Conversation!
Want to share your thoughts, add context, or connect with others in your community? Create a free account to comment on stories, ask questions, and join meaningful discussions on our new site.
Leave a Reply
You must be logged in to post a comment.